101 related articles for article (PubMed ID: 8361211)
1. Analysis of Pim-1 function in mutant mice.
Domen J; van der Lugt NM; Laird PW; Saris CJ; Berns A
Leukemia; 1993 Aug; 7 Suppl 2():S108-12. PubMed ID: 8361211
[TBL] [Abstract][Full Text] [Related]
2. Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells.
Domen J; van der Lugt NM; Laird PW; Saris CJ; Clarke AR; Hooper ML; Berns A
Blood; 1993 Sep; 82(5):1445-52. PubMed ID: 7689870
[TBL] [Abstract][Full Text] [Related]
3. Pim-1 levels determine the size of early B lymphoid compartments in bone marrow.
Domen J; van der Lugt NM; Acton D; Laird PW; Linders K; Berns A
J Exp Med; 1993 Nov; 178(5):1665-73. PubMed ID: 8228813
[TBL] [Abstract][Full Text] [Related]
4. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1.
Liang H; Hittelman W; Nagarajan L
Arch Biochem Biophys; 1996 Jun; 330(2):259-65. PubMed ID: 8660654
[TBL] [Abstract][Full Text] [Related]
6. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.
Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A
Oncogene; 1997 Sep; 15(10):1133-41. PubMed ID: 9294606
[TBL] [Abstract][Full Text] [Related]
7. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
Wingett D; Long A; Kelleher D; Magnuson NS
J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
[TBL] [Abstract][Full Text] [Related]
8. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
Zörnig M; Schmidt T; Karsunky H; Grzeschiczek A; Möröy T
Oncogene; 1996 Apr; 12(8):1789-801. PubMed ID: 8622900
[TBL] [Abstract][Full Text] [Related]
9. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related.
Lilly M; Le T; Holland P; Hendrickson SL
Oncogene; 1992 Apr; 7(4):727-32. PubMed ID: 1314369
[TBL] [Abstract][Full Text] [Related]
10. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.
Mikkers H; Nawijn M; Allen J; Brouwers C; Verhoeven E; Jonkers J; Berns A
Mol Cell Biol; 2004 Jul; 24(13):6104-15. PubMed ID: 15199164
[TBL] [Abstract][Full Text] [Related]
11. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
Breuer M; Wientjens E; Verbeek S; Slebos R; Berns A
Cancer Res; 1991 Feb; 51(3):958-63. PubMed ID: 1988138
[TBL] [Abstract][Full Text] [Related]
12. Murine KIT+ lineage- bone marrow progenitors express Fc gamma-RII but do not express Fc epsilon-RI until mast cell granule formation.
Lantz CS; Huff TF
J Immunol; 1995 Jan; 154(1):355-62. PubMed ID: 7527815
[TBL] [Abstract][Full Text] [Related]
13. Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells.
Buckley AR; Leff MA; Buckley DJ; Magnuson NS; de Jong G; Gout PW
Cell Growth Differ; 1996 Dec; 7(12):1713-21. PubMed ID: 8959340
[TBL] [Abstract][Full Text] [Related]
14. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
15. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes.
Wingett D; Reeves R; Magnuson NS
J Immunol; 1991 Nov; 147(10):3653-9. PubMed ID: 1940364
[TBL] [Abstract][Full Text] [Related]
16. The serine/threonine kinase Pim-1.
Bachmann M; Möröy T
Int J Biochem Cell Biol; 2005 Apr; 37(4):726-30. PubMed ID: 15694833
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice as a means to study synergism between oncogenes.
Berns A; Breuer M; Verbeek S; van Lohuizen M
Int J Cancer Suppl; 1989; 4():22-5. PubMed ID: 2681009
[TBL] [Abstract][Full Text] [Related]
18. Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells.
te Riele H; Maandag ER; Clarke A; Hooper M; Berns A
Nature; 1990 Dec; 348(6302):649-51. PubMed ID: 2250720
[TBL] [Abstract][Full Text] [Related]
19. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
20. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice.
Breuer M; Slebos R; Verbeek S; van Lohuizen M; Wientjens E; Berns A
Nature; 1989 Jul; 340(6228):61-3. PubMed ID: 2786994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
